<DOC>
	<DOCNO>NCT00199771</DOCNO>
	<brief_summary>The purpose study determine whether infusion hypertonic saline dextran attenuate inflammatory response water overload , major cardiac surgery small child .</brief_summary>
	<brief_title>Hypertonic Saline Dextran Pediatric Cardiac Surgery</brief_title>
	<detailed_description>After major cardiac surgery small child , extravasation fluid due increase capillary leak negative effect haemodynamics respiration . Inflammation cascade activate surgery use cardio pulmonary bypass ( CPB ) . We want test whether small infusion 7.5 % NaCl 6 % dextran solution CPB reduce inflammatory activation measuring level interleukins 6 8 ( IL-6 , IL-8 ) . We also measure extravascular lung water , fluid balance weight first 24 hour post CPB .</detailed_description>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Septal Defects , Ventricular</mesh_term>
	<mesh_term>Transposition Great Vessels</mesh_term>
	<mesh_term>Endocardial Cushion Defects</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Patients congenital heart defect undergo surgery use cardio pulmonary bypass ( CPB ) . Age 17 week Preoperative : organ failure ( heart ) , serum sodium &gt; 155 mmol/l , central venous pressure &gt; 12 mmHg Perioperative : core temperature &lt; 25 ÂºC CPB , reheparinization , reoperation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Weeks</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Infant</keyword>
	<keyword>Infant , Newborn</keyword>
	<keyword>Hypertonic Solutions</keyword>
	<keyword>Saline Solution , Hypertonic</keyword>
	<keyword>Capillary leak</keyword>
	<keyword>Inflammation Mediators</keyword>
</DOC>